Glipizide ER (extended release) is a medication used to treat type 2 diabetes. It is a sulfonylurea drug, which works by stimulating the pancreas to produce more insulin. It is a long-acting form of glipizide, which is a generic drug. Glipizide ER is a once-daily medication that helps to control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or insulin. The aim of this article is to provide a comprehensive review of glipizide ER, including its effectiveness, side effects, and safety.
Glipizide ER is an extended-release form of glipizide, a generic drug. It works by stimulating the pancreas to produce more insulin. Insulin is a hormone that helps the body use glucose from carbohydrates in the food we eat for energy or to store glucose for future use. Glipizide ER is usually taken once daily, usually in the morning. It is usually taken with food to reduce the risk of low blood sugar.
Studies have shown that glipizide ER is effective in controlling blood sugar levels in people with type 2 diabetes. In a 12-week study of over 400 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing fasting blood glucose levels. In another study of over 500 people with type 2 diabetes, glipizide ER was found to be more effective than placebo in reducing HbA1c levels.
Like all medications, glipizide ER can cause side effects. Common side effects include nausea, headache, dizziness, and diarrhea. Less common side effects include skin rash, weight gain, and abdominal pain. Rare side effects include low blood sugar (hypoglycemia) and an allergic reaction.
Glipizide ER is generally safe when taken as directed. It is important to follow the instructions of your healthcare provider when taking this medication. It is also important to monitor your blood sugar levels regularly and to report any changes to your healthcare provider.
In conclusion, glipizide ER is an effective medication for controlling blood sugar levels in people with type 2 diabetes. It is usually taken once daily and is usually taken with food to reduce the risk of low blood sugar. Common side effects include nausea, headache, dizziness, and diarrhea. It is important to follow the instructions of your healthcare provider and to monitor your blood sugar levels regularly.
1.
Sub-Q Ketamine is Safe and Very Effective for Severe Depression.
2.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
3.
Contradictory Results Are Found in Two Pembrolizumab Trials for Head and Neck Cancer.
4.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
5.
Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
3.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
4.
Polycythemia Vera: A Historical Perspective and Contemporary Management
5.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation